Generic Name and Formulations:
Racepinephrine 2.25%; inh soln.
Indications for ASTHMANEFRIN:
For temporary relief of shortness of breath, tightness of chest, and wheezing due to bronchial asthma.
Adults and Children:
For use in an atomizer (eg, EZ Breathe Atomizer). Add contents of one vial (0.5mL) to atomizer. <4yrs: not recommended. ≥4yrs: 1–3 inhalations not more than every 3 hours.
Within 14 days of MAOIs.
Heart disease. Hypertension. Thyroid disease. Diabetes. GI or GU obstruction. Asthma requiring hospitalization. Discontinue and reevaluate if symptoms are not relieved within 20 minutes or worsen. Do not use if product is brown, pinkish or darker than slightly yellow in color, if it appears cloudy, or if it contains a precipitate. Pregnancy. Nursing mothers.
Caution with concomitant other asthma drugs.
Nervousness, tachycardia with excessive use.
Starter Kit—1 (10 vials + 1 EZ Breathe Atomizer); Refill vials—30
Clinical Pain Advisor Articles
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- A Physician's Guide to Incorporating Patient Spirituality in Practice
- Low Literacy Self-Management Program for Chronic Pain May Be Effective
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- The Challenge of Compassion in Modern Healthcare Settings
- Republican Opposition to Obamacare: What's Done, What's to Come
- Lowering Default Pill Counts in EMRs May Effectively Reduce Postoperative Opioid Prescription Numbers
- Steps Taken to Increase Use of Electronic Tools in Medicine
- Daily and Retrospective Pain Measurements Comparable in Hip Osteoarthritis